Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Benjamin D. Ferguson, Maria S. Tretiakova, Mark W. Lingen, Parkash S. Gill & Ravi Salgia. (2014) Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies – implications for solid tumors and potential for therapeutic inhibition. Growth Factors 32:6, pages 202-206.
Read now
Read now
Mark G. Coulthard, Jason D. Lickliter, Nadesapillai Subanesan, Ke Chen, Graham C. Webb, Amanda J. Lowry, Simon Koblar, Cynthia D.K. Bottema & Andrew W. Boyd. (2001) Characterization of the EphA1 Receptor Tyrosine Kinase: Expression in Epithelial Tissues. Growth Factors 18:4, pages 303-317.
Read now
Read now
Articles from other publishers (22)
Ioanna E. Stergiou, Stavros P. Papadakos, Anna Karyda, Ourania E. Tsitsilonis, Meletios-Athanasios Dimopoulos & Stamatios Theocharis. (2023) EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. Cancers 15:15, pages 3963.
Crossref
Crossref
Kalpana K. Bhanumathy, Amrutha Balagopal, Frederick S. Vizeacoumar, Franco J. Vizeacoumar, Andrew Freywald & Vincenzo Giambra. (2021) Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia. Cancers 13:2, pages 184.
Crossref
Crossref
Sara Charmsaz, Andrew M. Scott & Andrew W. Boyd. (2017) Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors. Experimental Hematology 54, pages 31-39.
Crossref
Crossref
Akil A. MerchantAparna JorapurAmy McManusRen LiuValery KrasnoperovParvesh ChaudhryMohan SinghLisa HartonMary AgajanianMiriam KimTimothy J. TricheJrJrBrian J. Druker, Jeffrey W. Tyner & Parkash S. Gill. (2017) EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT. Blood Advances 1:20, pages 1635-1644.
Crossref
Crossref
S Charmsaz, F Al-Ejeh, T M Yeadon, K J Miller, F M Smith, B W Stringer, A S Moore, F-T Lee, L T Cooper, C Stylianou, G T Yarranton, J Woronicz, A M Scott, M Lackmann & A W Boyd. (2017) EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia. Leukemia 31:8, pages 1779-1787.
Crossref
Crossref
Sara Charmsaz, Kirrilee Beckett, Fiona M. Smith, Claudia Bruedigam, Andrew S. Moore, Fares Al-Ejeh, Steven W. Lane & Andrew W. Boyd. (2015) EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia. PLOS ONE 10:6, pages e0130692.
Crossref
Crossref
Alison Maddigan, Luke Truitt, Ryan Arsenault, Tanya Freywald, Odette Allonby, Jonathan Dean, Aru Narendran, Jim Xiang, Andrew Weng, Scott Napper & Andrew Freywald. (2011) EphB Receptors Trigger Akt Activation and Suppress Fas Receptor-Induced Apoptosis in Malignant T Lymphocytes. The Journal of Immunology 187:11, pages 5983-5994.
Crossref
Crossref
Min-A Seol, In-Sun Chu, Mi-Jin Lee, Goung-Ran Yu, Xiang-Dan Cui, Baik-Hwan Cho, Eun-Kyung Ahn, Sun-Hee Leem, In-Hee Kim & Dae-Ghon Kim. (2011) Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma. BMC Cancer 11:1.
Crossref
Crossref
Mario Mancino, Elisabet Ametller, Pedro Gascón & Vanessa Almendro. (2011) The neuronal influence on tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1816:2, pages 105-118.
Crossref
Crossref
Michael J. Ting, Bryan W. Day, Mark D. Spanevello & Andrew W. Boyd. (2010) Activation of ephrin A proteins influences hematopoietic stem cell adhesion and trafficking patterns. Experimental Hematology 38:11, pages 1087-1098.
Crossref
Crossref
Luis M. Alonso-C, Eva Ma. Trinidad, Beatriz de Garcillan, Monica Ballesteros, Milagros Castellanos, Ignacio Cotillo, Juan J. Muñoz & Agustin G. Zapata. (2009) Expression profile of Eph receptors and ephrin ligands in healthy human B lymphocytes and chronic lymphocytic leukemia B-cells. Leukemia Research 33:3, pages 395-406.
Crossref
Crossref
M. Tachibana, Y. Tonomoto, R. Hyakudomi, M. Hyakudomi, S. Hattori, S. Ueda, S. Kinugasa & H. Yoshimura. (2007) Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma. Digestive and Liver Disease 39:8, pages 725-732.
Crossref
Crossref
Rizwan Masood, S. Ram Kumar, Uttam K. Sinha, David L. Crowe, Valery Krasnoperov, Ramachandra K. Reddy, Sergey Zozulya, Jasbir Singh, Guangbin Xia, Daniel Broek, Axel H. Schönthal & Parkash S. Gill. (2006) EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. International Journal of Cancer 119:6, pages 1236-1248.
Crossref
Crossref
Qi‐Xiang Li, Philip Tan, Ning Ke & Flossie Wong‐Staal. 2006. Genomics in Cancer Drug Discovery and Development. Genomics in Cancer Drug Discovery and Development
103
143
.
Hongyu Luo, Guang Yu, Johanne Tremblay & Jiangping Wu. (2004) EphB6-null mutation results in compromised T cell function. Journal of Clinical Investigation 114:12, pages 1762-1773.
Crossref
Crossref
Hanna Surawska, Patrick C. Ma & Ravi Salgia. (2004) The role of ephrins and Eph receptors in cancer. Cytokine & Growth Factor Reviews 15:6, pages 419-433.
Crossref
Crossref
Guang Yu, Hongyu Luo, Yulian Wu & Jiangping Wu. (2003) Mouse EphrinB3 Augments T-cell Signaling and Responses to T-cell Receptor Ligation. Journal of Biological Chemistry 278:47, pages 47209-47216.
Crossref
Crossref
Guang Yu, Hongyu Luo, Yulian Wu & Jiangping Wu. (2003) Ephrin B2 Induces T Cell Costimulation. The Journal of Immunology 171:1, pages 106-114.
Crossref
Crossref
Masaru Nakamoto & Andrew D. Bergemann. (2002) Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microscopy Research and Technique 59:1, pages 58-67.
Crossref
Crossref
Xianyong MaTupur HusainHui PengSharon LinOlga MironenkoNoel MaunSteven JohnsonDavid TuckNancy BerlinerDiane S. KrauseArchibald S. Perkins. (2002) Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA library. Blood 100:3, pages 833-844.
Crossref
Crossref
Juan J. Muñoz, Luis M. Alonso-C.Rosa Sacedón, Tessa Crompton, Angeles Vicente, Eva Jiménez, Alberto Varas & Agustín G. Zapata. (2002) Expression and Function of the Eph A Receptors and Their Ligands Ephrins A in the Rat Thymus. The Journal of Immunology 169:1, pages 177-184.
Crossref
Crossref
Zhengyu WangNobuyuki MiuraAndres BonelliPamela MoleNadia CarlessoDouglas P. OlsonDavid T. Scadden. (2002) Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells. Blood 99:8, pages 2740-2747.
Crossref
Crossref